Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
amgen
boston blog main
clinical trials
inclisiran
life sciences
national blog main
new york
new york blog main
new york top stories
pcsk9 inhibitors
2
×
regeneron pharmaceuticals
alirocumab
biotech
boston top stories
cholesterol
drugs
evercore isi
evolocumab
heart attack
joseph swartz
medicines co.
national top stories
praluent
repatha
rna interference
stroke
svb leerink
the medicines co.
umer raffat
What
cholesterol
drug
lowering
2
×
medco
2
×
medicines
alnylam
based
bringing
clears
closer
data
evidence
fda
filing
heart
inched
lasting
long
looms
market
morning
new
partner
pharmaceuticals
phase
positive
preps
presented
reckoning
result
rna
supporting
term
tests
touting
touts
twice
use
yearly
Language
unset
Current search:
medco
×
lowering
×
" pcsk9 inhibitors "
×
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms